Effect and mechanism of Phillyrin on acute lung injury in septic shock mice

Expand
  • 1. Department of Emergency, the First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, China; 2. School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou 510080, China

Received date: 2023-07-10

  Online published: 2024-04-22

Abstract

Objective    To investigate the impact of phillyrin on acute lung injury (ALI) in septic shock mice through autophagy mediated by adenosine monophosphate activated protein kinase (AMPK)/mammalian target of rapamycin (mTOR)/p70 S6 kinase(p70S6K) signal pathway.    Methods    Twelve mice were randomly selected as the control group, and the rest of the mice were injected intraperitoneally with 20 mg·kg-1 LPS to construct the model of septic shock, the mice with septic shock were randomly divided into a model group, an Experimental-L, -M, -H group (5 mg·kg-1, 10 mg·kg-1, 20 mg·kg-1 phillyrin), and an Experimental -H+compound C group (20 mg·kg-1 phillyrin+20 mg·kg-1 AMPK inhibitor compound C), there were 12 mice in each group. The lung dry weight and wet weight were weighed, and the W/D ratio was calculated; the levels of inflammatory factors tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), interleukin-6 (IL-6) in BALF, serum endotoxin (ET) and myeloperoxidase (MPO) of lung tissue were detected by ELISA; HE staining was applied to detect pathological changes of lung tissue; Western blot was applied to detect the expression of autophagic proteins microtubule-associated protein -light chain 3 (LC3-II/I), Beclin 1, Ras-associated GTP binding protein 7 (Rab7), lysosomal associated membrane protein 2 (LAMP2) and AMPK/mTOR/p70S6K signaling pathway proteins.    Results    In control group, model group, Experimental-L,-M,-H group and Experimental-H+compound C group LC3-II/I ratios were 1.43±0.14, 0.73±0.07, 0.81±0.07, 1.12±0.10, 1.39±0.13, 0.76±0.08, respectively. Beclin1 protein levels were 1.05±0.11, 0.43±0.05, 0.50±0.05, 0.76±0.08, 0.98±0.10, 0.46±0.05, respectively. Rab7 protein levels were 1.53±0.17, 0.67±0.06, 0.70±0.07, 1.04±0.10, 1.41±0.14, 0.69±0.06, respectively. LAMP2 protein levels were 1.47±0.15, 0.72±0.07, 0.81±0.08, 1.09±0.11, 1.35±0.13, 0.74±0.07, respectively. p-AMPK/AMPK protein levels were 0.95±0.05, 0.33±0.03, 0.39±0.04, 0.68±0.07, 0.91±0.09, 0.36±0.04, respectively. p-mTOR/mTOR protein levels were 0.28±0.02, 0.94±0.06, 0.88±0.07, 0.57±0.05, 0.30±0.03, 0.87±0.09, respectively. The protein levels of p70S6K were 0.32±0.07, 0.96±0.04, 0.90±0.07, 0.69±0.06, 0.38±0.04, 0.92±0.06, respectively. There were statistical differences between the model group and the control group (all P<0.05). There were statistical differences between Experimental-M, -H group and model group (all P<0.05). There were significant differences between Experimental-H+compound C group and Experimental-H group (all P<0.05).   Conclusions   Phillyrin may improve ALI in septic shock mice by regulating autophagy mediated by AMPK/mTOR/p70S6K signaling pathway.

Cite this article

Zhang Fan, Wei Huanjie, Li Long, Ouyang Tao, Cai Juan, Liang Qiuling, Zeng Yuhui . Effect and mechanism of Phillyrin on acute lung injury in septic shock mice[J]. Chinese Journal of Clinical Anatomy, 2024 , 42(2) : 186 -190 . DOI: 10.13418/j.issn.1001-165x.2024.2.12

References

[1]  Liu XW, Ma T, Cai Q, et al. Elevation of serum PARK7 and IL-8 levels vs associated with acute lung injury in patients with severe sepsis/septic shock[J]. J Intensive Care Med, 2019, 34(8):662-668. DOI: 10.1177/0885066617709689.    

[2] Zhou C, Lu M, Cheng J, et al. Review on the pharmacological properties of phillyrin[J]. Molecules, 2022, 27(12):3670-3682. DOI: 10.3390/molecules27123670.
[3] Zhong WT, Wu YC, Xie XX, et al. Phillyrin attenuates LPS-induced pulmonary inflammation via suppression of MAPK and NF-κB activation in acute lung injury mice[J]. Fitoterapia, 2013, 90:132-139. DOI: 10.1016/j.fitote.2013.06.003.
[4] Shao BZ, Wang SL, Fang J, et al. Alpha7 nicotinic acetylcholine receptor alleviates inflammatory bowel disease through induction of AMPK-mTOR-p70S6K-mediated autophagy[J]. Inflammation, 2019, 42(5):1666-1679. DOI: 10.1007/s10753-019-01027-9.
[5]  Zhao H, Chen H, Meng XY, et al. Autophagy activation improves lung injury and inflammation in sepsis[J]. Inflammation, 2019, 42(2):426-439. DOI: 10.1007/s10753-018-00952-5.
[6]  Shao F, Zhou L, Zhang Y, et al. Gastrodin alleviates inflammatory injury of cardiomyocytes in septic shock mice via inhibiting NLRP3 expression[J]. In Vitro Cell Dev Biol Anim, 2021, 57(5):571-581. DOI: 10.1007/s11626-021-00593-3.
[7]  王小青, 王剑, 赵诗云, 等. 穿心莲内酯对小鼠早期感染性休克的影响[J]. 实用中西医结合临床, 2016, 16(8):76-78.
[8]  Di S, Wang Z, Hu W, et al. The protective effects of melatonin against LPS-induced septic myocardial injury: A potential role of AMPK-mediated autophagy[J]. Front Endocrinol (Lausanne), 2020, 11:162-181. DOI: 10.3389/fendo.2020.00162.
[9]  侯良绢, 李晓朋, 赵春娥, 等. 黄芪注射液对肺结核大鼠免疫功能、自噬和凋亡的影响[J]. 中国临床药理学杂志, 2022, 38(10):1092-1096. DOI: 10.13699/j.cnki.1001-6821.2022.10.016.
[10] Shi X, Li T, Liu Y, et al. HSF1 protects sepsis-induced acute lung injury by inhibiting NLRP3 inflammasome activation[J]. Front Immunol, 2022, 13:781003. DOI: 10.3389/fimmu.2022.781003.
[11] 常保超, 潘艳, 郭亚玲, 等. 白芍总苷通过增加糖尿病大鼠肾组织自噬活性减轻肾损伤的研究[J]. 中国临床药理学杂志, 2023, 39(7):984-988. DOI: 10.13699/j.cnki.1001-6821.2023.07.016.
[12] 田华, 郭连军, 刘富, 等. 葛根素下调Atg5、LC3Ⅰ/Ⅱ蛋白对缺血再灌注脑损伤小鼠的神经保护作用[J]. 中国临床药理学杂志, 2023, 39(4):508-512. DOI: 10.13699/j.cnki.1001-6821.2023.04.011.
[13]辛颖, 员丽培, 王峰, 等. 麦冬皂苷D调控磷酸酶及张力蛋白同源物诱导激酶1/帕金蛋白通路对脓毒症心肌损伤的保护作用[J]. 中国临床药理学杂志, 2023, 39(7):971-975. DOI: 10.13699/j.cnki.1001-6821.2023.07.013.
[14] Sun J, Mu Y, Jiang Y, et al. Inhibition of p70 S6 kinase activity by A77 1726 induces autophagy and enhances the degradation of superoxide dismutase 1 (SOD1) protein aggregates[J]. Cell Death Dis, 2018, 9(3):407-422. DOI: 10.1038/s41419-018-0441-0.
[15]Hu Y, Tao Y, Hu J. Cannabinoid receptor 2 deletion deteriorates myocardial infarction through the down-regulation of AMPK-mTOR-p70S6K signaling-mediated autophagy[J]. Biosci Rep, 2019, 39(4):BSR20180650. DOI: 10.1042/BSR20180650.

Outlines

/